Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor

Joleen M. Hubbard, Axel Grothey

Research output: Contribution to journalReview articlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences